These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 24272362)

  • 1. The role of complement in tumor growth.
    Pio R; Corrales L; Lambris JD
    Adv Exp Med Biol; 2014; 772():229-62. PubMed ID: 24272362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement as a Biological Tool to Control Tumor Growth.
    Macor P; Capolla S; Tedesco F
    Front Immunol; 2018; 9():2203. PubMed ID: 30319647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and the complement cascade.
    Rutkowski MJ; Sughrue ME; Kane AJ; Mills SA; Parsa AT
    Mol Cancer Res; 2010 Nov; 8(11):1453-65. PubMed ID: 20870736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement and cancer: activation of the alternative pathway as a theoretical base for immunotherapy.
    Cooper PD
    Adv Immun Cancer Ther; 1985; 1():125-66. PubMed ID: 3916662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement in monoclonal antibody therapy of cancer.
    Rogers LM; Veeramani S; Weiner GJ
    Immunol Res; 2014 Aug; 59(1-3):203-10. PubMed ID: 24906530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelinated dorsal root ganglion cultures activate both the alternative and classical pathways of complement.
    Scott-Zaki P; Purkall D; Bigbee J; Ruddy S; Yu RK
    J Neurol Sci; 1999 Jun; 165(2):160-9. PubMed ID: 10450802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiology and pathophysiology of complement: progress and trends.
    Morgan BP
    Crit Rev Clin Lab Sci; 1995; 32(3):265-98. PubMed ID: 7495498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the complement system in cancer.
    Afshar-Kharghan V
    J Clin Invest; 2017 Mar; 127(3):780-789. PubMed ID: 28248200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement inhibition in cancer therapy.
    Pio R; Ajona D; Lambris JD
    Semin Immunol; 2013 Feb; 25(1):54-64. PubMed ID: 23706991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement system as a target in cancer immunotherapy.
    Merle NS; Roumenina LT
    Eur J Immunol; 2024 Oct; 54(10):e2350820. PubMed ID: 38996361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting complement-mediated immunoregulation for cancer immunotherapy.
    Kolev M; Markiewski MM
    Semin Immunol; 2018 Jun; 37():85-97. PubMed ID: 29454575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.
    Finn OJ
    Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii6-9. PubMed ID: 22918931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy.
    Lebegge E; Arnouk SM; Bardet PMR; Kiss M; Raes G; Van Ginderachter JA
    Front Immunol; 2020; 11():1395. PubMed ID: 32733461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy.
    Geller A; Yan J
    Front Immunol; 2019; 10():1074. PubMed ID: 31164885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual role of complement in cancers, from destroying tumors to promoting tumor development.
    Lu P; Ma Y; Wei S; Liang X
    Cytokine; 2021 Jul; 143():155522. PubMed ID: 33849765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The complement system--structure, activation, regulation and function].
    Bjørge L
    Tidsskr Nor Laegeforen; 1999 Jan; 119(2):226-33. PubMed ID: 10081355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complex modulation by plasma proteins. With special reference to the complement system and autoimmune diseases.
    Baatrup G
    Dan Med Bull; 1989 Oct; 36(5):443-63. PubMed ID: 2530063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in cancer: Effects on tumor-associated myeloid cells and immunosuppression.
    Magrini E; Minute L; Dambra M; Garlanda C
    Semin Immunol; 2022 Mar; 60():101642. PubMed ID: 35842274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting innate immune pathways in cancer immunotherapy: state of the art.
    Mastellos DC
    J BUON; 2009 Sep; 14 Suppl 1():S123-30. PubMed ID: 19785054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Context-dependent roles of complement in cancer.
    Roumenina LT; Daugan MV; Petitprez F; Sautès-Fridman C; Fridman WH
    Nat Rev Cancer; 2019 Dec; 19(12):698-715. PubMed ID: 31666715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.